These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24835362)

  • 1. Establishing and sustaining a biorepository network in Israel: challenges and progress.
    Cohen Y; Almog R; Onn A; Itzhaki-Alfia A; Meir K
    Biopreserv Biobank; 2013 Dec; 11(6):331-8. PubMed ID: 24835362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Databases and Biobanks in Israel.
    Siegal G
    J Law Med Ethics; 2015; 43(4):766-75. PubMed ID: 26711416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a Synergistic Operating Model for Westmead Research Hub Biobanks: A Questionnaire Study.
    St George G; Wang XM; Linton J; Douglas N; Carpenter JE; Clarke CL; Heads JA
    Biopreserv Biobank; 2019 Dec; 17(6):570-576. PubMed ID: 31429584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biobanks in the low- and middle-income countries of the Arab Middle East region: challenges, ethical issues, and governance arrangements-a qualitative study involving biobank managers.
    Abdelhafiz AS; Ahram M; Ibrahim ME; Elgamri A; Gamel E; Labib R; Silverman H
    BMC Med Ethics; 2022 Aug; 23(1):83. PubMed ID: 35965314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Nice CHU biobank experience to collect patients' informed consent for research context (2004-2009)].
    Hofman V; Bonnetaud C; Gaziello MC; Ilie M; Lassalle S; Butori C; Lerda N; Selva E; Gavric-Tanga V; Castillo L; Guevara N; Santini J; Pop D; Vénissac N; Mouroux J; Chabannon C; Hofman P
    Ann Pathol; 2010 Oct; 30(5):337-43. PubMed ID: 21055520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taiwan Regulation of Biobanks.
    Fan CT; Hung TH; Yeh CK
    J Law Med Ethics; 2015; 43(4):816-26. PubMed ID: 26711420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tensions Between Policy and Practice in Finnish Biobank Legislation.
    Tupasela A
    Biopreserv Biobank; 2015 Oct; 13(5):379-81. PubMed ID: 26418975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Israel's population: the challenge of pluralism.
    Friedlander D; Goldscheider C
    Popul Bull; 1984 Apr; 39(2):3-39. PubMed ID: 12312873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a network-based intra-hospital virtual cancer biobank.
    Zhang L; Wu X; Hu Y; Wang X; He Z; Xie Y; Pan K; Wang N; Dong Z; Zhang L; Ji J
    Biopreserv Biobank; 2015 Feb; 13(1):43-8. PubMed ID: 25686047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The political economy of healthy system reform in Israel.
    Chernichovsky D; Chinitz D
    Health Econ; 1995; 4(2):127-41. PubMed ID: 7613597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ethical review of biobanks in The Netherlands: lessons from the String of Pearls Initiative].
    Boeckhout M; van Dijk J; Legemate DA
    Ned Tijdschr Geneeskd; 2011; 155(26):A3557. PubMed ID: 21767425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-objectifying European bodies: standardisation of biobanks in the Biobanking and Biomolecular Resources Research Infrastructure.
    Tamminen S
    Life Sci Soc Policy; 2015; 11():13. PubMed ID: 26626620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
    Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
    Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of biomaterials in liquid- and tissue-biobanking].
    Herpel E; Schmitt S; Kiehntopf M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):325-35. PubMed ID: 26753866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustainability of Biobanks in the Future.
    De Souza YG
    Adv Exp Med Biol; 2015; 864():29-35. PubMed ID: 26420611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IT solutions for privacy protection in biobanking.
    Eder J; Gottweis H; Zatloukal K
    Public Health Genomics; 2012; 15(5):254-62. PubMed ID: 22722689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biorepository regulatory frameworks: building parallel resources that both promote scientific investigation and protect human subjects.
    Marko-Varga G; Baker MS; Boja ES; Rodriguez H; Fehniger TE
    J Proteome Res; 2014 Dec; 13(12):5319-24. PubMed ID: 25277501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional and electronic informed consent for biobanking: a survey of U.S. biobanks.
    Simon CM; Klein DW; Schartz HA
    Biopreserv Biobank; 2014 Dec; 12(6):423-9. PubMed ID: 25496155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.